Medgenome Labs Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
- Paid Up Capital ₹ 2.84 Cr
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.30 Cr
- Satisfied Charges ₹ 55.27 Cr
- Revenue Growth 30.88%
- Profit Growth 193.77%
- Ebitda 40.56%
- Net Worth 371.25%
- Total Assets 37.82%
About Medgenome Labs
Medgenome Labs Limited (MLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 08 April 2013 and has a history of 11 years and nine months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Medgenome Labs Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 2.84 Cr.
The company currently has active open charges totaling ₹3.30 Cr. The company has closed loans amounting to ₹55.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Medgenome Labs Limited India are Surajit Chakrabartty as CFO and Suryaprakasam Ramprasad as Ceo. Prasad Shejale, Balamaniamma Nair, Mahesh Pratapneni, and Two other members serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U73100KA2013PLC084414
-
Company No.
084414
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
08 Apr 2013
-
Date of AGM
13 Nov 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Medgenome Labs?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Surajit Chakrabartty | CFO | 01-Dec-2014 | Current |
Suryaprakasam Ramprasad | CEO | 05-Dec-2024 | Current |
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prasad Shejale | Director | 30-Sep-2019 | Current |
Balamaniamma Nair | Director | 08-Apr-2013 | Current |
Mahesh Pratapneni | Director | 30-Sep-2014 | Current |
Shankar Prasad | Director | 24-Dec-2018 | Current |
Navjeewan Khosla | Additional Director | 07-Nov-2024 | Current |
Financial Performance of Medgenome Labs.
Medgenome Labs Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.88% increase. The company also saw a substantial improvement in profitability, with a 193.77% increase in profit. The company's net worth Soared by an impressive increase of 371.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Medgenome Labs?
In 2021, Medgenome Labs had a promoter holding of 96.92% and a public holding of 3.07%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.30 Cr
₹55.27 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.30 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
28 Apr 2023 | Hdfc Bank Limited | ₹3.30 Cr | Open |
26 Jun 2019 | Others | ₹9.10 Cr | Satisfied |
15 Mar 2019 | Hdfc Bank Limited | ₹16.92 Cr | Satisfied |
02 Jun 2015 | Hdfc Bank Limited | ₹29.25 Cr | Satisfied |
How Many Employees Work at Medgenome Labs?
Medgenome Labs has a workforce of 883 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medgenome Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medgenome Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.